Minerva Neurosciences (NERV) Prepaid Assets (2013 - 2026)
Minerva Neurosciences (NERV) posted Prepaid Assets of $941883.0 for Q1 2026, up 35.0% on a QoQ basis from $697676.0 in Q4 2025, and up 76.12% year-over-year from $534798.0 in Q1 2025.
Minerva Neurosciences (NERV) Prepaid Assets (2013 - 2026) Analysis & Trends
Minerva Neurosciences' Prepaid Assets history runs 14 years deep, the most recent figure standing at $941883.0 for Q1 2026.
- Quarterly Prepaid Assets rose 76.12% year-over-year to $941883.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $941883.0 (up 76.12% YoY) and the FY2025 annual result came in at $697676.0, down 13.54% from the prior year.
- Prepaid Assets was $941883.0 for Q1 2026 at Minerva Neurosciences, up from $697676.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.4 million in Q3 2022 and bottomed at $184821.0 in Q2 2022.
- A 5-year average of $733855.5 and a median of $697676.0 in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets plunged 79.7% — and 2023, when it jumped 78.09%.
- Minerva Neurosciences' Prepaid Assets stood at $848117.0 in 2022, then gained by 16.71% to $989865.0 in 2023, then fell by 18.48% to $806895.0 in 2024, then slipped by 13.54% to $697676.0 in 2025, then soared by 35.0% to $941883.0 in 2026.
- Business Quant data shows NERV's Prepaid Assets at $941883.0 in Q1 2026, $697676.0 in Q4 2025, and $633533.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 941,883.00 |
| Dec 31, 2025 | 697,676.00 |
| Sep 30, 2025 | 633,533.00 |
| Jun 30, 2025 | 199,615.00 |
| Mar 31, 2025 | 534,798.00 |
| Dec 31, 2024 | 806,895.00 |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 428,018.00 |
| Mar 31, 2024 | 702,546.00 |
| Dec 31, 2023 | 989,865.00 |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 329,153.00 |
| Mar 31, 2023 | 596,045.00 |
| Dec 31, 2022 | 848,117.00 |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 184,821.00 |
| Mar 31, 2022 | 650,481.00 |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 910,577.00 |